GE’s health unit wins first FDA clearance for A.I.-powered X-ray system

The Food and Drug Administration has cleared a new artificial intelligence-powered X-ray device that maker GE Healthcare says reduces the time to detect a collapsed lung from eight hours to as little as 15 minutes, the company announced Thursday.

The device, called the Critical Care Suite, uses AI algorithms to scan X-ray images and detect pneumothorax, a deadly condition more commonly known as a collapsed lung that affects roughly 74,000 Americans each year.

“The health-care industry is producing huge amounts of data from images to digital health records,” GE Healthcare CEO Kieran Murphy said in an interview with CNBC ahead of the announcement. “We strongly believe that you have to turn that data into information and insight to improve outcomes.”

GE Healthcare, a dominant player in hospital and lab equipment, said its goal is to integrate AI into every aspect of the health-care system to ultimately “improve patient outcomes, reduce waste and inefficiencies, and eliminate costly errors.”

The General Electric unit’s technology, developed with scientist at the University of California, San Francisco, is trained to detect pneumothorax, but the company said it’s working to enhance it to detect other health conditions.

The technology works by using AI to analyze images from an X-ray, the company said. If a condition is suspected — in this case, pneumothorax— the image is sent directly to the radiologist for review. The technology functions outside the cloud and isn’t dependent on an internet connection, the company said.

By Berkeley Lovelace Jr. | CNBC

Image Credit: Getty Images

READ MORE

About Peter Coffaro 504 Articles
Peter Coffaro is a growth-driven and strategic executive with over 25 years of progressive management success in the medical device industry. With a proven track record and recognized expertise, Peter has established himself as one of the top influencers in medical sales, as acknowledged by prestigious publications such as the World Journal of Orthopedics, Exponential Healthtech, and MedReps.com. Throughout his career, Peter has accumulated 10 years of combined sales management experience, excelling in various roles including Director, General Manager, Distributor, and Vice President. He has worked for industry-leading orthopedic companies such as Zimmer, DePuy, and Stryker, solidifying his deep knowledge and network within the field. Peter’s passion for innovation and emerging technologies led him to found OrthoFeed, an award-winning blog covering digital orthopedic news and emerging medical technologies. Through this platform, he stays at the forefront of the industry and contributes to the dissemination of valuable insights. Peter is a three-time Hall of Fame award winner at Johnson and Johnson, demonstrating his exceptional contributions and impact on the organization. His expertise extends to areas such as organizational development, business development, sales management, digital marketing, and professional education. Peter earned a B.S. degree in Biology and Chemistry from Northern Illinois University, further complementing his comprehensive understanding of the medical field. With his wealth of experience, strategic mindset, and dedication to advancing healthcare, Peter Coffaro is a valuable asset and leader in the medical device industry.

Be the first to comment

Leave a Reply

Your email address will not be published.


*


This site uses Akismet to reduce spam. Learn how your comment data is processed.